Prostate cancer treatment may harm your heart – new study investigates

NCT ID NCT05320406

Ongoing Knowledge-focused Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 31 times

Summary

This study looks at how hormone therapy for prostate cancer affects the heart. Researchers will compare three treatment groups: radiation alone, radiation with leuprolide, and radiation with relugolix. The goal is to understand why some men develop heart problems and find ways to reduce that risk. About 94 men with non-metastatic prostate cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I PROSTATE CANCER AJCC V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Emory Proton Therapy Center

Atlanta, Georgia, 30308, United States
Emory Saint Joseph's Hospital

Atlanta, Georgia, 30342, United States
Emory University Hospital Midtown

Atlanta, Georgia, 30308, United States
Emory University/Winship Cancer Institute

Atlanta, Georgia, 30322, United States

Conditions

Explore the condition pages connected to this study.